These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 7622422

  • 1. Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.
    Miyagi E, Yasumitsu H, Hirahara F, Minaguchi H, Koshikawa N, Miyazaki K, Umeda M.
    Jpn J Cancer Res; 1995 Jun; 86(6):568-76. PubMed ID: 7622422
    [Abstract] [Full Text] [Related]

  • 2. Invasiveness corresponds to differentiation rather than to proteinase secretion in endometrial cancer cell lines.
    Sillem M, Prifti S, Koumouridis A, Runnebaum B.
    Eur J Gynaecol Oncol; 1999 Jun; 20(5-6):367-70. PubMed ID: 10609496
    [Abstract] [Full Text] [Related]

  • 3. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma.
    Moser TL, Young TN, Rodriguez GC, Pizzo SV, Bast RC, Stack MS.
    Int J Cancer; 1994 Feb 15; 56(4):552-9. PubMed ID: 8112891
    [Abstract] [Full Text] [Related]

  • 4. Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines.
    Kawamata H, Nakashiro K, Uchida D, Harada K, Yoshida H, Sato M.
    Int J Cancer; 1997 Jan 06; 70(1):120-7. PubMed ID: 8985100
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.
    Sharma RK.
    In Vivo; 1998 Jan 06; 12(2):209-17. PubMed ID: 9627804
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity.
    Netzel-Arnett S, Mitola DJ, Yamada SS, Chrysovergis K, Holmbeck K, Birkedal-Hansen H, Bugge TH.
    J Biol Chem; 2002 Nov 22; 277(47):45154-61. PubMed ID: 12192005
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.
    Vacca A, Ribatti D, Iurlaro M, Albini A, Minischetti M, Bussolino F, Pellegrino A, Ria R, Rusnati M, Presta M, Vincenti V, Persico MG, Dammacco F.
    Int J Clin Lab Res; 1998 Nov 22; 28(1):55-68. PubMed ID: 9594364
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
    Paju A, Sorsa T, Tervahartiala T, Koivunen E, Haglund C, Leminen A, Wahlström T, Salo T, Stenman UH.
    Br J Cancer; 2001 May 18; 84(10):1363-71. PubMed ID: 11355948
    [Abstract] [Full Text] [Related]

  • 13. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
    Naka T, Kuester D, Boltze C, Schulz TO, Samii A, Herold C, Ostertag H, Roessner A.
    Hum Pathol; 2008 Feb 18; 39(2):217-23. PubMed ID: 17949787
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Loss of the metastatic phenotype by a human epidermoid carcinoma cell line, HEp-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2.
    Testa JE.
    Cancer Res; 1992 Oct 15; 52(20):5597-603. PubMed ID: 1327511
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
    Schwartz JD, Shamamian P, Monea S, Whiting D, Marcus SG, Galloway AC, Mignatti P.
    Surgery; 1998 Aug 15; 124(2):232-8. PubMed ID: 9706143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.